arrow
S

Stefano Ziccardi

university of verona
H指数:12
被引数:482

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Age-Stratified Comparison of Gait Biomechanics in People with Relapsing–Remitting Multiple Sclerosis and Healthy Individuals: An Exploratory Cross-Sectional Study

按年龄分层比较复发-缓解型多发性硬化症患者与健康个体的步态生物力学:一项探索性横断面研究

2026-10-190
OA
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes

奥法木单抗治疗多发性硬化的真实世界有效性与安全性:一项整合临床、认知和MRI结局的纵向研究

2026-04-070
PRE
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis

认知超越复发:独立于复发活动的认知进展反映了多发性硬化中的早期潜行神经退行性变

2026-02-160
OAAI
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis

克立布林片对复发缓解型多发性硬化鞘内炎症的影响

2026-02-120
OAAI
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands

多发性硬化症的诊断及其在出现第四型“镜像模式”脑脊液寡克隆带患者的鉴别诊断

2025-02-150
OA
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage
2024-11-010
OAAI
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis

早期多发性硬化中CSF骨桥蛋白水平与皮质萎缩和残疾的关系

2024-09-011
OAAI
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis

几丁质酶3 like1的CSF水平与多发性硬化症中对克拉屈滨的早期反应相关

2024-02-092
OAAI